Navigation Links
Symposium focuses on patient safety in CT scanning
Date:5/13/2010

ATLANTA, GA (May 13, 2010) -- A national summit of medical professionals meeting last month in Atlanta called for the creation of consensus scan techniques as a way of addressing the concerns of patients undergoing CT scans -- a common medical imaging procedure that uses X-rays to show cross-sectional images of the body.

The summit brought together some of the world's leading experts in CT imaging, including medical physicists, radiologists, technologists, and equipment manufacturers. It was hosted by the American Association of Physicists in Medicine (AAPM), a professional organization whose members include board-certified health professionals and research scientists specializing in the use of radiation in medicine.

According to Cynthia McCollough, Ph.D., Professor of Radiologic Physics at the Mayo Clinic, who co-organized the meeting on behalf of AAPM, the summit achieved its goal of identifying several issues that need to be dealt with by the medical imaging community in order to address the safety concerns of patients at U.S. hospitals and clinics.

In the last several months, many medical physicists have witnessed first-hand how some patients have grown concerned about stories in the media questioning the risks and challenging the safety of CT scans.

"We all hear it every day. Patients ask, 'do I really need to have this procedure?'," said Dianna Cody, Ph.D., another co-organizer of the meeting. Cody, who is Professor of Imaging Physics at the University of Texas M. D. Anderson Cancer Center, says that patients should not be afraid of getting medically appropriate CT exams. "When medically justified," she said, "the benefits of CT scans far outweigh the risks."

Even so, patients' fears are very real. The CT Dose Summit arose partly as a response to these fears, as leaders within the AAPM CT community discussed what more professionals in their field could do to ensure patient safety and to reassure patients coming for CT.

These discussions led directly to the summit, one outcome of which was a call for imaging professionals and equipment manufacturers to precisely define and use a consistent set of terminology to eliminate ambiguity when staff move between different types of scanners or when technical issues are discussed with staff who have different backgrounds.

The summit also made the case for developing consensus CT protocols and making them freely available via the Internet to hospitals and clinics across the United States. CT protocols -- or scan instructions -- identify the equipment settings and define starting points for a given procedure. Because protocols determine the quality of a CT exam and the amount of radiation used, they must be optimized to deliver the quality needed to make a confident diagnosis and to keep the doses as low as reasonably achievable.

Up to now, hospitals and imaging centers have developed their own protocols, typically based on recommendations from the manufacturer. However, many in the field have pointed out that with the increased capabilities and complexities of modern CT systems, it does not make sense for each institution to develop its own protocols.

AAPM has long led efforts to support the use of standards for measuring and minimizing radiation dose in medical applications, including CT procedures. Hospitals and clinics employ AAPM members to review CT protocols and check the proper functioning of scanners. Organizing the summit was a logical extension of this work.

"We were responding to what we heard from many professionals, calling for consensus protocols that would improve and standardize image quality and reduce radiation dose," said McCollough, who is a medical physicist and director of Mayo Clinic's CT Clinical Innovation Center in Rochester, MN. "In Atlanta, we laid the groundwork for medical professionals, manufacturers who make and market medical scanners, and government regulators to work together to develop these protocols."

"This effort will go a long way toward addressing patient safety concerns and ensuring that CT exams are performed as safely and effectively as possible," said William Hendee, PhD, the third co-organizer of the meeting. Hendee is Chair of AAPM's Technology Assessment Initiative and a professor at the Medical College of Wisconsin, Marquette University, and the University of Wisconsin - Milwaukee.

At the summit, speakers reviewed the fundamental principles of protocol design and examined several protocols developed at some of the nation's largest and most prestigious hospitals. These protocols cover the most common types of CT exams, from routine imaging of the head and body, to newer applications such as cardiac CT and CT perfusion imaging.

The AAPM started its protocol optimization with CT perfusion, the highest-dose CT procedure. Their consensus guidelines will soon be publicly available to help practices nationwide make sure they are performing this examination correctly.

"This provides us with strategies on how to reduce overall dose to patients," said Bob Turco of West County Radiology Group in St. Louis, MO.


'/>"/>

Contact: Jason Socrates Bardi
jbardi@aip.org
301-209-3091
American Institute of Physics
Source:Eurekalert

Related medicine news :

1. Plastic Surgery Website Design Firm Rosemont Media Heads to Miami for the 44th Annual Baker Gordon Symposium
2. Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium
3. ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum
4. Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned
5. Agendia to Present Broad Array of Data at 2009 San Antonio Breast Cancer Symposium
6. Press Ganey Announces 2010 Regional Education Symposium Schedule
7. H1N1 international symposium to be hosted by Emory-UGA Influenza Center
8. GUMCs Lombardi Hosts Symposium Exploring Future of Cancer Research and Personalized Medicine
9. Food and Addiction Symposium on Friday, Feb. 19
10. Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium
11. North American Spine Joins Governor Arnold Schwarzenegger at 2010 ICA Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: